Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis
- PMID: 39062550
- PMCID: PMC11275061
- DOI: 10.3390/biom14070836
Antioxidant, Anti-Inflammatory, Anti-Diabetic, and Pro-Osteogenic Activities of Polyphenols for the Treatment of Two Different Chronic Diseases: Type 2 Diabetes Mellitus and Osteoporosis
Abstract
Polyphenols are natural bioactives occurring in medicinal and aromatic plants and food and beverages of plant origin. Compared with conventional therapies, plant-derived phytochemicals are more affordable and accessible and have no toxic side effects. Thus, pharmaceutical research is increasingly inclined to discover and study new and innovative natural molecules for the treatment of several chronic human diseases, like type 2 diabetes mellitus (T2DM) and osteoporosis. These pathological conditions are characterized by a chronic inflammatory state and persistent oxidative stress, which are interconnected and lead to the development and worsening of these two health disorders. Oral nano delivery strategies have been used to improve the bioavailability of polyphenols and to allow these natural molecules to exert their antioxidant, anti-inflammatory, anti-diabetic, and pro-osteogenic biological activities in in vivo experimental models and in patients. Polyphenols are commonly used in the formulations of nutraceuticals, which can counteract the detrimental effects of T2DM and osteoporosis pathologies. This review describes the polyphenols that can exert protective effects against T2DM and osteoporosis through the modulation of specific molecular markers and pathways. These bioactives could be used as adjuvants, in combination with synthetic drugs, in the future to develop innovative therapeutic strategies for the treatment of T2DM and osteoporosis.
Keywords: anti-diabetic; anti-inflammatory; antioxidant; osteoporosis; polyphenols; pro-osteogenic; type 2 diabetes mellitus.
Conflict of interest statement
Emanuele-Salvatore Scarpa is an employee of Mivell S.r.l.s. and is the inventor of European Patent Application EP 4 205 733 A1. The other authors declare no conflicts of interest.
Figures
References
-
- Matacchione G., Valli D., Silvestrini A., Giuliani A., Sabbatinelli J., Giordani C., Coppari S., Rippo M.R., Albertini M.C., Olivieri F. Curcumin, Polydatin and Quercetin Synergistic Activity Protects from High-Glucose-Induced Inflammation and Oxidative Stress. Antioxidants. 2022;11:1037. doi: 10.3390/antiox11061037. - DOI - PMC - PubMed
-
- Scarpa E.S., Giordani C., Antonelli A., Petrelli M., Balercia G., Silvetti F., Pieroni A., Sabbatinelli J., Rippo M.R., Olivieri F., et al. The Combination of Natural Molecules Naringenin, Hesperetin, Curcumin, Polydatin and Quercetin Synergistically Decreases SEMA3E Expression Levels and DPPIV Activity in In Vitro Models of Insulin Resistance. Int. J. Mol. Sci. 2023;24:8071. doi: 10.3390/ijms24098071. - DOI - PMC - PubMed
-
- Giordani C., Matacchione G., Giuliani A., Valli D., Scarpa E.S., Antonelli A., Sabbatinelli J., Giacchetti G., Sabatelli S., Olivieri F., et al. Pro-Osteogenic and Anti-Inflammatory Synergistic Effect of Orthosilicic Acid, Vitamin K2, Curcumin, Polydatin and Quercetin Combination in Young and Senescent Bone Marrow-Derived Mesenchymal Stromal Cells. Int. J. Mol. Sci. 2023;24:8820. doi: 10.3390/ijms24108820. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
